Get access

The biology and pathology of the familial Parkinson's disease protein LRRK2

Authors

  • William Dauer MD,

    Corresponding author
    1. Department of Neurology, Columbia University, New York, New York, USA
    2. Department of Pharmacology, Columbia University, New York, New York, USA
    • Departments of Neurology and Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109
    Search for more papers by this author
  • Cherry Cheng-Ying Ho

    1. Department of Neurology, Columbia University, New York, New York, USA
    Search for more papers by this author

  • Potential conflict of interest: None reported.

Abstract

Parkinson's disease (PD) is typically a sporadic illness, but the past decade has witnessed the identification of mutations responsible for multiple familial forms of the disease. The proposed functions of some of these genes (e.g., E3 ubiquitin ligase, redox-dependent chaperone) have led to the hypothesis that dysfunction of protein quality control pathways contributes to PD neurodegeneration. However, the key signaling events that act downstream of misfolded proteins to cause cell death remain poorly defined. The discovery of the familial PD kinase leucine-rich repeat kinase 2 (LRRK2) holds great promise for the elucidation of signaling events relevant to PD neurodegeneration. This review will summarize current knowledge of the clinical and cell biological features of LRRK2, the most common inherited cause of Parkinsonism. © 2010 Movement Disorder Society

Get access to the full text of this article

Ancillary